A series of octahydroquinazoline-5-ones as novel inhibitors against dengue virus.

作者: Yihong Wan , Shengen Wu , Sichao Zheng , En Liang , Shuwen Liu

DOI: 10.1016/J.EJMECH.2020.112318

关键词:

摘要: Abstract A series of octahydroquinazoline-5-ones (OHQs 1–50) were designed and synthesized via an improved five-component reaction (5CR). Their bioactivities against dengue virus (DENV) evaluated by determining lacate dehydrogenase (LDH) in the BHK-21 cells infected with DENV-2. Primary structure-activity relationship showed that six OHQs suitable substituents displayed good activities EC50 = 1.31–1.85 μM. The primary bioactivity mechanism was investigated using most potent OHQ 23. Experimental results indicate 23 could efficiently reverse DENV-2-induced cytopathic effect suppress expression viral structure E protein, but no interaction MTase RdRp domain NS5, a protein plays important role genome transcription translation. efficient synthetic method, novel structures as DENV inhibitors are expected to be developed potential inhibitors.

参考文章(33)
Qiuhua Zhu, Lan Huang, Zhipeng Chen, Sichao Zheng, Longyun Lv, Zhibo Zhu, Derong Cao, Huanfeng Jiang, Shuwen Liu, A New Series of C‐6 Unsubstituted Tetrahydropyrimidines: Convenient One‐Pot Chemoselective Synthesis, Aggregation‐Induced and Size‐Independent Emission Characteristics Chemistry: A European Journal. ,vol. 19, pp. 1268- 1280 ,(2013) , 10.1002/CHEM.201203012
Chih-Hua Tseng, Chun-Kuang Lin, Yeh-Long Chen, Chih-Yao Hsu, Huey-Nan Wu, Chin-Kai Tseng, Jin-Ching Lee, Synthesis, antiproliferative and anti-dengue virus evaluations of 2-aroyl-3-arylquinoline derivatives. European Journal of Medicinal Chemistry. ,vol. 79, pp. 66- 76 ,(2014) , 10.1016/J.EJMECH.2014.03.074
Hemalatha Beesetti, Navin Khanna, Sathyamangalam Swaminathan, Drugs for dengue: a patent review (2010 – 2014) Expert Opinion on Therapeutic Patents. ,vol. 24, pp. 1171- 1184 ,(2014) , 10.1517/13543776.2014.967212
Milind Saudi, Joanna Zmurko, Suzanne Kaptein, Jef Rozenski, Johan Neyts, Arthur Van Aerschot, Synthesis and evaluation of imidazole-4,5- and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus. European Journal of Medicinal Chemistry. ,vol. 87, pp. 529- 539 ,(2014) , 10.1016/J.EJMECH.2014.09.062
Christian G. Noble, Yen-Liang Chen, Hongping Dong, Feng Gu, Siew Pheng Lim, Wouter Schul, Qing-Yin Wang, Pei-Yong Shi, Strategies for development of Dengue virus inhibitors. Antiviral Research. ,vol. 85, pp. 450- 462 ,(2010) , 10.1016/J.ANTIVIRAL.2009.12.011
Goro Kuno, Gwong-Jen J. Chang, K. Richard Tsuchiya, Nick Karabatsos, C. Bruce Cropp, Phylogeny of the Genus Flavivirus Journal of Virology. ,vol. 72, pp. 73- 83 ,(1998) , 10.1128/JVI.72.1.73-83.1998
Jane P Messina, Oliver J Brady, David M Pigott, John S Brownstein, Anne G Hoen, Simon I Hay, None, The global distribution and burden of dengue Nature. ,vol. 496, pp. 504- 507 ,(2013) , 10.1038/NATURE12060
Hong-Tao Xu, Susan P. Colby-Germinario, Said Hassounah, Peter K. Quashie, Yingshan Han, Maureen Oliveira, Brent R. Stranix, Mark A. Wainberg, Identification of a pyridoxine-derived small-molecule inhibitor targeting dengue virus RNA-dependent RNA polymerase Antimicrobial Agents and Chemotherapy. ,vol. 60, pp. 600- 608 ,(2016) , 10.1128/AAC.02203-15